DOCSLIB.ORG

25. C:\Documents and Settings\Kwang-Il\My

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
25. C:\Documents and Settings\Kwang-Il\My The human disease network Goh K-I, Cusick ME, Valle D, Childs B, Vidal M, Barabasi′ A-L (2007) Proc Natl Acad Sci USA 104:8685-8690 Disorder Class Bone Coats Cancer Urolithiasise Osteopetrosis disease NDP Caffey van_Buchem Exudative Cardiovascular disease disease vitreoretinopathy Norrie SLC34A1 disease 439 LRP5 Connective tissue disorder Nevo Hyperostosis, syndrome COL1A1 endosteal Dermatological PLOD1 217 PAX9 Oligodontia Osteogenesis Osteoporosis 1164 Developmental Ehlers-Danlos imperfecta syndrome Arthropathy COL3A1 Hypodontia Ear, Nose, Throat Aneurysm, COL1A2 familial_arterial Myasthenic Witkop 733 syndrome Heart syndrome Pseudoachondroplasia Endocrine 3-methylglutaconicaciduria OPA3 WISP3 Optic Marfan block MSX1 atrophy OPA1 Aortic syndrome Paramyotonia Sick_sinus Gastrointestinal aneurysm congenita syndrome 3558 Intervertebral_disc Brugada SCN4A disease syndrome Syndactyly Spondyloepiphyseal COMP COL9A2 Hematological Glaucoma Weill-Marchesani Shprintzen-Goldberg Cramps, SCN5A Zlotogora-Ogur Cleft dysplasia syndrome syndrome potassium-aggravated Myotonia 2785 syndrome palate Parkes_Weber Basal_cell FBN1 congenita Oculodentodigital COL9A3 1432 Immunological 1414 CYP1B1 syndrome nevus_syndrome MASS Hypokalemic Acquired dysplasia Peters long_QT_syndrome Epiphyseal FLNB RASA1 PTCH Keratitis syndrome periodic MATN3 Metabolic SHH anomaly Eye Ectopia Thyrotoxic paralysis dysplasia Atelosteogenesis anomalies Marshall Larson Capillary Basal_cell Holoprosencephaly Coloboma, periodic KCNH2 PVRL1 malformations GJA1 Incontinentia syndrome SLC26A2 syndrome carcinoma ocular paralysis pigmenti Muscular PTCH2 26 Long_QT Wagner Osteoarthritis Diastrophic Aniridia, IKBKG syndrome PAX6 type_II CACNA1S syndrome dysplasia Neurological Optic_nerve Morning COL11A1 Medulloblastoma Branchiootic EYA1 Atrioventricular Ectodermal syndrome hypoplasia/aplasia glory Foveal KCNE1 Achondrogenesis_Ib Nutritional disc hypoplasia block LOR dysplasia SMED Rieger COL2A1 Strudwick_type syndrome anomaly 942 PITX2 FOXC1 126 Kniest Ophthamological Ring_dermoid PITX3 CPT 830 Bart-Pumphrey Cataract deficiency, KCNE2 Erythrokeratoderma 1586 Stickler dysplasia of_cornea syndrome syndrome Iridogoniodysgenesis hepatic Vohwinkel Psychiatric NKX2-5 syndrome GJB6 Iris_hypoplasia RYR1 KCNQ1 843 OSMED Enhanced Bothnia Alagille retinal Renal and_glaucoma Axenfeld Tetralogy GJB3 syndrome S-cone 1105 1104 anomaly CRYAB CPT2 syndrome GJB2 syndromedystrophy Butterfly Maculopathy, of_Fallot 845 COL11A2 bull’s-eye Respiratory Atrial Fechtner 549 dystrophy, Central_core 792 May-Hegglin syndrome retinal Self-healing disease fibrillation JAG1 Retinal_cone NR2E3 RLBP1 collodion_baby anomaly Epstein dsytrophy Skeletal 1518 Fundus KRT10 syndrome albipunctatus Macular Epidermolytic EBD Miyoshi VMD2 396 Toenail MYH9 NRL RDS dystrophy multiple hyperkeratosis dystrophy, myopathy Myopathy MYH7 Sebastian Vitelliform TGM1 isolated DYSF Becker MYH6 syndrome Night macular 434 MYF6 ELOVL4 1401 Myotilinopathy muscular Duchenne Deafness blindness ABCA4 Stargardt dystrophy Unclassified Ichthyosiform COL7A1 DES muscular MYO7A RHO erythroderma Ichthyosis 847 dystrophy disease KRT1 DSP Rippling_muscle dystrophy PCDH15 Creatine disease DMD PDE6B Retinitis 1229 STS MYOT EYA4 TIMM8A CRB1 Epidermolysis PLEC1 phosphokinase CDH23 Disorder Name 5233 144 Muscular Usher USH2A LAMA3 bullosa USH1C pigmentosa CRX 1545 868 CAV3 Mohr-Tranebjaerg COCH syndrome Cone Somatotrophinoma RYR2 Walker-Warburg FCMD dystrophy DSPP 18 Acampomelic campolelic dysplasia Ventricular syndrome TTN Cardiomyopathy syndromeJensen AIPL1 dystrophy Dentin MASS1 GUCY2D 26 Achondrogenesis-hypochondrogenesis, type II McCune-Albright tachycardia POMT1 syndromeMeniere SLC26A4 syndrome SGCD PRKAG2 dysplasia, RPE65 53 Adrenal hyperplasia, congenital GRACILE disease type_II 77 Aldosterone to renin ratio raised GNAI2 syndrome Alexander Wolff-Parkinson-White Convulsions Menkes GNAS 1232 BCS1L disease TCAP Pendred 418 RPGR disease 87 Alpha-1-antichymotrypsin deficiency Osseous syndrome Leber RPGRIP1 TAZ Enlarged syndrome RP1 92 Alpha-thalassemia/mental retardation syndrome heteroplasia NDUFV1 vestibular Roussy-Levy 1016 COX15 Barth congenital_amaurosis 96 Alternating hemiplegia of childhood aqueduct ATP7A Occipital_horn 107 Analgesia from kappa-opioid receptor agonist, female-specific syndrome SDHA Leigh syndrome syndrome Acromegaly 117 Angiotensin I-converting enzyme 474 1113 Macular Cutis Dejerine-Sottas NDUFS4 syndrome Hemolytic-uremic FBLN5 laxa 126 Anterior segment anomalies and cataract syndrome degeneration Williams-Beuren Pseudohypoparathyroidism disease PMP22 1297 LMNA 129 Anxiety-related personality traits PDHA1 CFH CNGB3 ELN syndrome 137 Apparent mineralocorticoid excess, hypertension due to Vertical GCSL 144 Arrhythmogenic right ventricular dysplasia EGR2 Achromatopsia talus Maple_syrup_urine Stroke Factor_x Hypertriglyceridemia Supravalvar_aortic 162 Athabaskan brainstem dysgenesis syndrome Neuropathy disease MPZ Rabson-Mendenhall deficiency stenosis 171 Attention-deficit hyperactivity disorder HOXD10 syndrome 182 Bannayan-Riley-Ruvalcaba syndrome 192 Beare-Stevenson cutis gyrata syndrome 913 HSPB1 Pelizaeus-Merzbacher Charcot-Marie-Tooth 1396 3212 Leprechaunism Nephropathy-hypertension 198 Beta-2-adrenoreceptor agonist, reduced response to ALOX5AP F7 disease Spastic_ataxia DCTN1 disease Apolipoprotein 210 Blepharophimosis, epicanthus inversus, and ptosis PLP1 INSR Hypoalphalipoproteinemia 217 Bone mineral density variability /paraplegia Amyotrophic 1347 594 deficiency APOA2 ALS2 GARS BSCL2 KCNJ11 275 Carpal tunnel syndrome, familial Primary lateral HEXB Lipodystrophy Hypoglycemia 279 Cavernous malformations of CNS and retina APOA1 Hypercholesterolemia lateral_sclerosis sclerosis Insulin ABCC8 117 287 Central hypoventilation syndrome VAPB Spinal_muscular resistance Hyperproinsulinemia TCF2 Myocardial Corneal 292 Cerebrooculofacioskeletal syndrome atrophy SARS, 294 Cerebrovascular disease, occlusive 803 progression_of dystrophy APOB PAFAH1B1 Hyperinsulinism infarction 275 COL8A2 313 Cholesteryl ester storage disease FOXP3 Amyloidosis Hypobetalipoproteinemia INS THBD VSX1 558 320 Choreoathetosis, hypothyroidism, and respiratory distress 1456 Diabetes TTR 329 Chylomicronemia syndrome, familial Coumarin Squamous_cell Myeloperoxidase APOE Amyloid Lissencephaly Nicotine Sea-blue_histiocyte FGA 344 Cold-induced autoinflammatory syndrome resistance CYP2A6 Non-Hodgkin carcinoma PPARG ACE deficiency Dysfibrinogenemia neuropathy Keratoconus addiction CHRNA4 mellitus disease Abetalipoproteinemia 347 Colonic aganglionosis, total, with small bowel involvement DCX LGI1 lymphoma GCK MPO 463 Infantile_spasm Epilepsy 377 357 Conotruncal anomaly face syndrome syndrome GABRG2 HNF4A Hyperproreninemia Afibrinogenemia 377 Craniofacial anomalies, empty sella turcica, corneal endothelial changes 2385 ACSL6 Glioblastoma MODY Hyperlipoproteinemia Myoclonic Myelodysplastic Renal FGB 378 Craniofacial-deafness-hand syndrome epilepsy KCNQ2 syndrome FAS IPF1 SLC2A2 REN tubular APP Hypofibrinogenemia 379 Craniofacial-skeletal-dermatologic dysplasia Coffin-Lowry SLC6A8 CACNB4 Myelogenous Alzheimer FGG ARX CASP10 dysgenesis 396 Cyclic ichthyosis with epidermolytic hyperkeratosis syndrome 1057 Androgen leukemia Autoimmune Pancreatic Thrombophilia insensitivity ENPP1 disease 418 Dentinogenesis imperfecta, Shields type RPS6KA3 Mental Macrocytic disease agenesis Fanconi-Bickel 137 422 Dermatofibrosarcoma protuberans Ataxia Perineal anemia syndrome RETN AGT F5 Hemorrhagic retardation IRF1 930 AGTR1 CBS diathesis 434 Dilated cardiomyopathy with woolly hair and keratoderma Partington hypospadias 438 Disordered steroidogenesis, isolated Gastric CASP8 HSD11B2 EPHX1 SERPINA1 Emphysema NLGN4X syndrome AR ERBB2 1153 Preeclampsia 439 Dissection of cervical arteries Asperger Proud 379 cancer Adenoma, Muir-Torre PTPN22 syndrome syndrome Apert Listeria periampullary syndrome TCF1 Hypercholanemia Homocystinuria 441 Dopamine beta-hydroxylase deficiency syndrome 192 Nonsmall_cell Coronary Thrombocytopenia monocytogenes Ataxia-telangiectasia Obesity NOS3 452 Dyggve-Melchior-Clausen disease Saethre-Chotzen Desmoid lung_cancer Cafe-au-lait 198 spasms 453 Dysalbuminemic hyperthyroxinemia NLGN3 MECP2 syndrome Schizophrenia Autism SOX3 disease spots Placental 461 Dyssegmental dysplasia, Silverman-Handmaker type Pfeiffer KLF6 1183 ATM MSH2 Hypertension PRODH Wiskott-Aldrich FGD1 Adenomas Ovarian abruption syndrome 463 Dystransthyretinemic hyperthyroxinemia syndrome FGFR2 Gardner MLH1 ADRB2 NR3C2 Hyperprolinemia WAS cancer Pilomatricoma Systemic_lupus Allergic PSEN1 471 Elite sprint athletic performance 809 Jackson-Weiss syndrome CDH1 BRCA1 rhinitis PPM-X Angelman APC Turcot erythematosus SCNN1B 474 Emery-Dreifuss muscular dystrophy syndrome CTNNB1 EGFR Pseudohypoaldosteronism syndrome Rett syndrome MUTYH MAD1L1 Neuroectodermal syndrome AGRP Pick 527 Fatty liver, acute, of pregnancy Leanness, IL13 Atherosclerosis Seasonal 535 Fibrocalculous pancreatic diabetes syndrome FGFR1 Crouzon PIK3CA tumors Rheumatoid disease Neutropenia Aarskog-Scott Craniosynostosis syndrome Prostate PMS2 Hepatic inherited arthritis Liddle affective_disorder 539 Fibular hypoplasia and complex brachydactyly syndrome RAD54B Adenocarcinoma SCNN1G syndrome HTR2A FCGR3A 544 Fluorouracil toxicity, sensitivity to RAD54L Alcohol MSX2 cancer T-cell adenoma IL10 545 Focal cortical dysplasia, Taylor balloon cell type Kallmann ALOX5 dependence MXI1 lymphoblastic ECE1 ELA2 549 Foveomacular dystrophy, adult-onset, with choroidal
Load more

Recommended publications
  • Iron Dysregulation in Movement Disorders
    Neurobiology of Disease 46 (2012) 1–18 Contents lists available at SciVerse ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi Review Iron dysregulation in movement disorders Petr Dusek a,c, Joseph Jankovic a,⁎, Weidong Le b a Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA b Parkinson's Disease Research Laboratory, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA c Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic article info abstract Article history: Iron is an essential element necessary for energy production, DNA and neurotransmitter synthesis, myelination Received 9 November 2011 and phospholipid metabolism. Neurodegeneration with brain iron accumulation (NBIA) involves several genetic Revised 22 December 2011 disorders, two of which, aceruloplasminemia and neuroferritinopathy, are caused by mutations in genes directly Accepted 31 December 2011 involved in iron metabolic pathway, and others, such as pantothenate-kinase 2, phospholipase-A2 and fatty acid Available online 12 January 2012 2-hydroxylase associated neurodegeneration, are caused by mutations in genes coding for proteins involved in phospholipid metabolism. Phospholipids are major constituents of myelin and iron accumulation has been linked Keywords: Iron to myelin derangements. Another group of NBIAs is caused by mutations in lysosomal enzymes or transporters Neurodegeneration such as ATP13A2, mucolipin-1 and possibly also β-galactosidase and α-fucosidase. Increased cellular iron uptake Dystonia in these diseases may be caused by impaired recycling of iron which normally involves lysosomes.
    [Show full text]
  • Approach to a Case of Congenital Heart Disease
    BAI JERBAI WADIA HOSPITAL FOR CHILDREN PEDIATRIC CLINICS FOR POST GRADUATES PREFACE This book is a compilation of the discussions carried out at the course for post-graduates on ” Clinical Practical Pediatrics” at the Bai Jerbai Wadia Hospital for Children, Mumbai. It has been prepared by the teaching faculty of the course and will be a ready-reckoner for the exam-going participants. This manual covers the most commonly asked cases in Pediatric Practical examinations in our country and we hope that it will help the students in their practical examinations. An appropriately taken history, properly elicited clinical signs, logical diagnosis with the differential diagnosis and sound management principles definitely give the examiner the feeling that the candidate is fit to be a consultant of tomorrow. Wishing you all the very best for your forthcoming examinations. Dr.N.C.Joshi Dr.S.S.Prabhu Program Directors. FOREWARD I am very happy to say that the hospital has taken an initiative to organize this CME for the postgraduate students. The hospital is completing 75 years of its existence and has 2 done marvelous work in providing excellent sevices to the children belonging to the poor society of Mumbai and the country. The hospital gets cases referred from all over the country and I am proud to say that the referrals has stood the confidence imposed on the hospital and its faculty. We do get even the rarest of the rare cases which get diagnosed and treated. I am sure all of you will be immensely benefited by this programme. Wish you all the best in your examination and career.
    [Show full text]
  • Total Serum Phosphate Levels Less Than 3.0 Mg/Dl. • Mild Hypophosp
    HYPOPHOSPHATEMIA DEFINITION: Total serum phosphate levels less than 3.0 mg/dL. Mild hypophosphatemia: 2.5-3.0 mg/dL. Moderate hypophosphatemia: 1.0-2.5 mg/dL. Severe hypophosphatemia: < 1.0 mg/dL. INCIDENCE IN CRITICAL ILLNESS: Common. ETIOLOGY: Transcellular shift: Refeeding syndrome (abrupt initiation of carbohydrate causes an insulin spike, which increases cellular phosphate uptake); exogenous administration of insulin; respiratory alkalosis. Renal loss: Diuretics; osmotic diuresis in diabetic ketoacidosis; hyperparathyroidism (primary and secondary; decreases urinary resorption of phosphate); proximal renal tubular dysfunction (Fanconi’s syndrome). Insufficient intestinal absorption: Malnutrition; phosphate-binding antacids; vitamin D deficiency; chronic diarrhea; nasogastric tube suction; malabsorption. Extreme catabolic states: Burns; trauma; sepsis. CLINICAL MANIFESTATIONS: Cardiovascular: Acute left ventricular dysfunction; reversible dilated cardiomyopathy. Hematologic: Acute hemolytic anemia; leukocyte dysfunction. Neuromuscular: Diffuse skeletal muscle weakness; rhabdomyolysis; bone demineralization; acute and chronic respiratory failure secondary to diaphragmatic weakness (impaired ventilator weaning); confusion and lethargy; gait disturbance; paresthesias. TREATMENT: It is impossible to accurately predict the exact quantity of phosphate repletion required because most phosphate is intracellular. Moderate hypophosphatemia: Oral supplementation is usually adequate (provided the gastrointestinal tract is functional).
    [Show full text]
  • A Mutation in Lamin A/C Gene Previously Known to Cause Emery
    ical C lin as C e f R o l e a p n o r r t u s o J Journal of Clinical Case Reports Chalissery et al., J Clin Case Rep 2016, 6:4 ISSN: 2165-7920 DOI: 10.4172/2165-7920.1000770 Case Report Open Access A Mutation in Lamin A/C Gene Previously Known to Cause Emery- Driefuss Muscular Dystrophy Causing A Phenotype of Limb Girdle Muscular Dystrophy Type 1B Albi J Chalissery1*, Tudor Munteanu1, Yvonne Langan2, Francesca Brett2 and Janice Redmond1 1Department of Neurology, St James’s Hospital, Ireland 2Department of Neurophysiology, St James’s Hospital, Ireland 3Department of Neuropathology, Beaumont Hospital, Dublin, Ireland *Corresponding author: Albi J Chalissery, Department of Neurology, St James’s Hospital, James’s Street, Dublin 8, Ireland, Tel +353 1 410 3000; E-mail: [email protected] Rec date: Feb 19, 2016; Acc date: Apr 13, 2016; Pub date: Apr 18, 2016 Copyright: © 2016 Chalissery AJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Mutations in the lamin protein(found in the nuclear envelope) known to cause different allelic disorders including limb girdle muscular dystrophies (LGMD) and Emery-Dreifuss muscular dystrophy (EDMD). LGMDs are a heterogeneous group of disorders with progressive proximal muscle weakness in an autosomal inheritance pattern. LGMD type 1B is a disorder secondary to a mutation in the gene encoding Lamin A/C protein in the nuclear envelope.
    [Show full text]
  • Basilar Artery and Its Branches Called Pontine Arteries
    3 Farah Mohammad Ahmad Al-Tarefe Mohammad Al salem تذكر أ َّن : أولئك الذين بداخلهم شيء يفوق كل الظروف ، هم فقط من استطاعوا أ ّن يحققوا انجازاً رائعاً .... كن ذا همة Recommendation: Study this sheet after you finish the whole anatomy material . Dr.Alsalem started talking about the blood supply for brain and spinal cord which are mentioned in sheet#5 so that we didn't write them . 26:00-56:27/ Rec.Lab#3 Let start : Medulla oblengata : we will study the blood supply in two levels . A- Close medulla (central canal) : It is divided into four regions ; medial , anteromedial , posteriolateral and posterior region. Medially : anterior spinal artery. Anteromedial: vertebral artery posterolateral : posterior inferior cerebellar artery ( PICA). Posterior : posterior spinal artery which is a branch from PICA. B-Open medulla ( 4th ventricle ) : It is divided into four regions ; medial , anteromedial , posteriolateral region. Medially : anterior spinal artery. Anteromedial: vertebral artery posterolateral : posterior inferior cerebellar artery ( PICA). 1 | P a g e Lesions: 1- Medial medullary syndrome (Dejerine syndrome): It is caused by a lesion in anterior spinal artery which supplies the area close to the mid line. Symptoms: (keep your eyes on right pic). Contralateral hemiparesis= weakness: the pyramid will be affected . Contralateral loss of proprioception , fine touch and vibration (medial lemniscus). Deviation of the tongue to the ipsilateral side when it is protruded (hypoglossal root or nucleus injury). This syndrome is characterized by Alternating hemiplegia MRI from Open Medulla (notice the 4th ventricle) Note :The Alternating hemiplegia means ; 1- The upper and lower limbs are paralyzed in the contralateral side of lesion = upper motor neuron lesion .
    [Show full text]
  • Type II Familial Synpolydactyly: Report on Two Families with an Emphasis on Variations of Expression
    European Journal of Human Genetics (2011) 19, 112–114 & 2011 Macmillan Publishers Limited All rights reserved 1018-4813/11 www.nature.com/ejhg SHORT REPORT Type II familial synpolydactyly: report on two families with an emphasis on variations of expression Mohammad M Al-Qattan*,1 Type II familial synpolydactyly is rare and is known to have variable expression. However, no previous papers have attempted to review these variations. The aim of this paper was to review these variations and show several of these variable expressions in two families. The classic features of type II familial synpolydactyly are bilateral synpolydactyly of the third web spaces of the hands and bilateral synpolydactyly of the fourth web spaces of the feet. Several members of the two families reported in this paper showed the following variations: the third web spaces of the hands showing syndactyly without the polydactyly, normal feet, concurrent polydactyly of the little finger, concurrent clinodactyly of the little finger and the ‘homozygous’ phenotype. It was concluded that variable expressions of type II familial synpolydactyly are common and awareness of such variations is important to clinicians. European Journal of Human Genetics (2011) 19, 112–114; doi:10.1038/ejhg.2010.127; published online 18 August 2010 Keywords: type II familial syndactyly; inherited synpolydactyly; variations of expression INTRODUCTION CASE REPORTS Type II familial synpolydactyly is rare and it has been reported in o30 The first family families.1–12 It is characterized by bilateral synpolydactyly of the third The family had a history of synpolydactyly type II for several web spaces of the hands and bilateral synpolydactyly of the fourth web generations on the mother’s side (Table 1).
    [Show full text]
  • The Genetic Basis for Skeletal Diseases
    insight review articles The genetic basis for skeletal diseases Elazar Zelzer & Bjorn R. Olsen Harvard Medical School, Department of Cell Biology, 240 Longwood Avenue, Boston, Massachusetts 02115, USA (e-mail: [email protected]) We walk, run, work and play, paying little attention to our bones, their joints and their muscle connections, because the system works. Evolution has refined robust genetic mechanisms for skeletal development and growth that are able to direct the formation of a complex, yet wonderfully adaptable organ system. How is it done? Recent studies of rare genetic diseases have identified many of the critical transcription factors and signalling pathways specifying the normal development of bones, confirming the wisdom of William Harvey when he said: “nature is nowhere accustomed more openly to display her secret mysteries than in cases where she shows traces of her workings apart from the beaten path”. enetic studies of diseases that affect skeletal differentiation to cartilage cells (chondrocytes) or bone cells development and growth are providing (osteoblasts) within the condensations. Subsequent growth invaluable insights into the roles not only of during the organogenesis phase generates cartilage models individual genes, but also of entire (anlagen) of future bones (as in limb bones) or membranous developmental pathways. Different mutations bones (as in the cranial vault) (Fig. 1). The cartilage anlagen Gin the same gene may result in a range of abnormalities, are replaced by bone and marrow in a process called endo- and disease ‘families’ are frequently caused by mutations in chondral ossification. Finally, a process of growth and components of the same pathway.
    [Show full text]
  • A Molecular and Genetic Analysis of Otosclerosis
    A molecular and genetic analysis of otosclerosis Joanna Lauren Ziff Submitted for the degree of PhD University College London January 2014 1 Declaration I, Joanna Ziff, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Where work has been conducted by other members of our laboratory, this has been indicated by an appropriate reference. 2 Abstract Otosclerosis is a common form of conductive hearing loss. It is characterised by abnormal bone remodelling within the otic capsule, leading to formation of sclerotic lesions of the temporal bone. Encroachment of these lesions on to the footplate of the stapes in the middle ear leads to stapes fixation and subsequent conductive hearing loss. The hereditary nature of otosclerosis has long been recognised due to its recurrence within families, but its genetic aetiology is yet to be characterised. Although many familial linkage studies and candidate gene association studies to investigate the genetic nature of otosclerosis have been performed in recent years, progress in identifying disease causing genes has been slow. This is largely due to the highly heterogeneous nature of this condition. The research presented in this thesis examines the molecular and genetic basis of otosclerosis using two next generation sequencing technologies; RNA-sequencing and Whole Exome Sequencing. RNA–sequencing has provided human stapes transcriptomes for healthy and diseased stapes, and in combination with pathway analysis has helped identify genes and molecular processes dysregulated in otosclerotic tissue. Whole Exome Sequencing has been employed to investigate rare variants that segregate with otosclerosis in affected families, and has been followed by a variant filtering strategy, which has prioritised genes found to be dysregulated during RNA-sequencing.
    [Show full text]
  • Diagnosis, Treatment and Follow Up
    DOI: 10.1002/jimd.12024 REVIEW International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up Ruqaiah Altassan1,2 | Romain Péanne3,4 | Jaak Jaeken3 | Rita Barone5 | Muad Bidet6 | Delphine Borgel7 | Sandra Brasil8,9 | David Cassiman10 | Anna Cechova11 | David Coman12,13 | Javier Corral14 | Joana Correia15 | María Eugenia de la Morena-Barrio16 | Pascale de Lonlay17 | Vanessa Dos Reis8 | Carlos R Ferreira18,19 | Agata Fiumara5 | Rita Francisco8,9,20 | Hudson Freeze21 | Simone Funke22 | Thatjana Gardeitchik23 | Matthijs Gert4,24 | Muriel Girad25,26 | Marisa Giros27 | Stephanie Grünewald28 | Trinidad Hernández-Caselles29 | Tomas Honzik11 | Marlen Hutter30 | Donna Krasnewich18 | Christina Lam31,32 | Joy Lee33 | Dirk Lefeber23 | Dorinda Marques-da-Silva9,20 | Antonio F Martinez34 | Hossein Moravej35 | Katrin Õunap36,37 | Carlota Pascoal8,9 | Tiffany Pascreau38 | Marc Patterson39,40,41 | Dulce Quelhas14,42 | Kimiyo Raymond43 | Peymaneh Sarkhail44 | Manuel Schiff45 | Małgorzata Seroczynska29 | Mercedes Serrano46 | Nathalie Seta47 | Jolanta Sykut-Cegielska48 | Christian Thiel30 | Federic Tort27 | Mari-Anne Vals49 | Paula Videira20 | Peter Witters50,51 | Renate Zeevaert52 | Eva Morava53,54 1Department of Medical Genetic, Montréal Children's Hospital, Montréal, Québec, Canada 2Department of Medical Genetic, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia 3Department of Human Genetics, KU Leuven, Leuven, Belgium 4LIA GLYCOLAB4CDG (International
    [Show full text]
  • Advances in Understanding the Genetics of Syndromes Involving Congenital Upper Limb Anomalies
    Review Article Page 1 of 10 Advances in understanding the genetics of syndromes involving congenital upper limb anomalies Liying Sun1#, Yingzhao Huang2,3,4#, Sen Zhao2,3,4, Wenyao Zhong1, Mao Lin2,3,4, Yang Guo1, Yuehan Yin1, Nan Wu2,3,4, Zhihong Wu2,3,5, Wen Tian1 1Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China; 2Beijing Key Laboratory for Genetic Research of Skeletal Deformity, Beijing 100730, China; 3Medical Research Center of Orthopedics, Chinese Academy of Medical Sciences, Beijing 100730, China; 4Department of Orthopedic Surgery, 5Department of Central Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China Contributions: (I) Conception and design: W Tian, N Wu, Z Wu, S Zhong; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: Y Huang; (V) Data analysis and interpretation: L Sun; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Wen Tian. Hand Surgery Department, Beijing Jishuitan Hospital, Beijing 100035, China. Email: [email protected]. Abstract: Congenital upper limb anomalies (CULA) are a common birth defect and a significant portion of complicated syndromic anomalies have upper limb involvement. Mostly the mortality of babies with CULA can be attributed to associated anomalies. The cause of the majority of syndromic CULA was unknown until recently. Advances in genetic and genomic technologies have unraveled the genetic basis of many syndromes- associated CULA, while at the same time highlighting the extreme heterogeneity in CULA genetics. Discoveries regarding biological pathways and syndromic CULA provide insights into the limb development and bring a better understanding of the pathogenesis of CULA.
    [Show full text]
  • Inherited Metabolic Disorders)
    1 โรคพันธุกรรมเมตาบอลิก (inherited metabolic disorders) บทนํา โรคพันธุกรรมเมตาบอลิคนั้น มีผู้ประเมินไว้ว่ามีหลายร้อยโรคด้วยกัน และเป็นที่ยอมรับว่า อุบัติการของโรคกลุ่มนี้มักจะน้อยกว่าความเป็นจริง เนื่องจากการวินิจฉัยโรคทําได้ด้วยความ ยากลําบาก แพทย์ทั่วไปมักรู้จักค่อนข้างน้อย หรือให้การวินิจฉัยไม่ถูกต้อง ด้วยเหตุผลหลาย ประการ 1). การวินิจฉัยทําได้ค่อนข้างยาก เนื่องจากแต่ละโรคพบได้น้อยคือ จัดเป็น rare disease ทําให้แพทย์ไม่ค่อยนึกถึงเมื่อพบผู้ป่วย จนอาการค่อนข้างมาก หรือเมื่อได้แยกโรคที่พบได้บ่อย ออกไปแล้ว 2). การตรวจทางห้องปฎิบัติการโดยเฉพาะการตรวจเลือดและปัสสาวะเบื้องต้น มักไม่ ค่อยบอกโรคชัดเจน ยกเว้นส่งตรวจพิเศษบางอย่างเช่นการวิเคราะห์ plasma amino acid หรือ urine organic acid 3). ในทารกแรกเกิดซึ่งมีโอกาสพบโรคกลุ่มนี้ได้บ่อย มักจะมีการตอบสนองต่อ severe overwhelming illness อย่างมีขีดจํากัด หรือแสดงอาการอย่าง nonspecific เช่น poor feeding,lethargy เป็นต้น 4).กุมารแพทย์คิดถึงโรคกลุ่มนี้ในบางภาวะเท่านั้นเช่นภาวะปัญญาอ่อน หรือชักที่คุมได้ยากและมองข้ามอาการแสดงบางอย่างที่อาจเป็นเงื่อนงําสําคัญในการวินิจฉัยโรค โรคพันธุกรรมเมตาบอลิก ที่เรียกว่า inherited metabolic disorders หรือ inborn errors of metabolism (IBEM) เป็นโรคพันธุกรรมกลุ่มหนึ่งที่เกิดจากความผิดปกติของยีนเดี่ยว ที่มีความ ผิดปกติของการเรียงลําดับของเบสหรือสายDNA ก่อให้เกิดความผิดปกติของ enzymes, receptors, transport proteins, structural proteins, หรือส่วนประกอบอื่นของเซลล์แล้วส่งผลให้ เกิดความผิดปกติของขบวนการย่อยสลาย (catabolism) หรือขบวนการสังเคราะห์ (anabolism) สารอาหาร การเปลี่ยนแปลงที่ระดับ DNA ของโรคกลุ่มนี้อาจเกิดจากการกลายพันธุ์ของยีนที่สร้าง enzyme หรือยีนที่สร้างสารควบคุมหรือส่งเสริมการทํางานของ
    [Show full text]
  • MICHIGAN BIRTH DEFECTS REGISTRY Cytogenetics Laboratory Reporting Instructions 2002
    MICHIGAN BIRTH DEFECTS REGISTRY Cytogenetics Laboratory Reporting Instructions 2002 Michigan Department of Community Health Community Public Health Agency and Center for Health Statistics 3423 N. Martin Luther King Jr. Blvd. P. O. Box 30691 Lansing, Michigan 48909 Michigan Department of Community Health James K. Haveman, Jr., Director B-274a (March, 2002) Authority: P.A. 236 of 1988 BIRTH DEFECTS REGISTRY MICHIGAN DEPARTMENT OF COMMUNITY HEALTH BIRTH DEFECTS REGISTRY STAFF The Michigan Birth Defects Registry staff prepared this manual to provide the information needed to submit reports. The manual contains copies of the legislation mandating the Registry, the Rules for reporting birth defects, information about reportable and non reportable birth defects, and methods of reporting. Changes in the manual will be sent to each hospital contact to assist in complete and accurate reporting. We are interested in your comments about the manual and any suggestions about information you would like to receive. The Michigan Birth Defects Registry is located in the Office of the State Registrar and Division of Health Statistics. Registry staff can be reached at the following address: Michigan Birth Defects Registry 3423 N. Martin Luther King Jr. Blvd. P.O. Box 30691 Lansing MI 48909 Telephone number (517) 335-8678 FAX (517) 335-9513 FOR ASSISTANCE WITH SPECIFIC QUESTIONS PLEASE CONTACT Glenn E. Copeland (517) 335-8677 Cytogenetics Laboratory Reporting Instructions I. INTRODUCTION This manual provides detailed instructions on the proper reporting of diagnosed birth defects by cytogenetics laboratories. A report is required from cytogenetics laboratories whenever a reportable condition is diagnosed for patients under the age of two years.
    [Show full text]